Mostly Markets
Subscribe
Stocks/Health Care/Health Care Services

CignaCI

Health Care Services · Bloomfield, Connecticut · In the S&P 500
Cheaper than peers
$298.23−0.06%After hours: $298.23 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 0.3% over 1 year
Cigna over 1 yearDaily close, $, to 30 Oct 2026
$260$280Nov2026MarMayJulSep$298.23$250NovMarJul$298.23
Source: Nasdaq daily closes
Market value$78.80B
Price to earnings12.4x
Forward P/E9.4x
Dividend yield2.09%
Year to date+8.4%
One year−0.3%
Next earningsThu 5 Nov, before the open
SectorHealth Care
52-week range (closes)
$244.41$315.88

Quality and valuation

How Cigna compares with other health care stocks. A description, not a recommendation.

Cigna and 5 health care services peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: cheaper than most

A weaker business than most health care companies, priced below most of them.

Cigna trades at 9.4 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +7.8% vs +7.8%
  • Keeps less of each sale (gross margin): 20.6% vs 65.3%
  • Less profitable (operating margin): 3.5% vs 13.3%
CI trades at 9.4x forward earnings, below the sector medianForward p/e, Health Care Services peers
CI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1xCI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 12.9x earnings, CI is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
20x30xAverage 18.4x2025202612.9x20x30xAverage 18.4x2025202612.9x
Source: Nasdaq prices; SEC filings

Financials

From Cigna's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 6.7% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0bn$20bn$40bn$60bnQ3 ’24Q1 ’25Q3 ’25$71.7bnQ2 ’26$0bn$25bn$50bnQ3 ’24Q1 ’25Q3 ’25$71.7bnQ2 ’26
Source: SEC filings
Growth sped up to +6.7% last quarterRevenue growth, year on year, %
0%10%20%Q3 ’24Q1 ’25Q3 ’256.7%Q2 ’260%10%20%Q3 ’24Q1 ’25Q3 ’256.7%Q2 ’26
Source: SEC filings
Operating margin was 3.7% last quarterOperating income as a share of revenue, %
0%1%2%3%4%Q3 ’24Q1 ’25Q3 ’253.7%Q2 ’260%2%4%Q3 ’24Q1 ’25Q3 ’253.7%Q2 ’26
Source: SEC filings
Diluted EPS was $6.29 last quarterQuarterly diluted earnings per share, $
$0$2$4$6Q3 ’24Q1 ’25Q3 ’25$6.29Q2 ’26$0$2$5Q3 ’24Q1 ’25Q3 ’25$6.29Q2 ’26
Source: SEC filings
Last 12 monthsCISector median
Revenue growth+7.8%+7.8%
Gross margin20.6%65.3%
Operating margin3.5%13.3%
Price to earnings12.4x30.2x

Stories on Cigna

We haven't written about Cigna yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Services, by market value.

CompanyPriceTodayYTDValue
CVSCVS Health$90.25−0.09%+13.7%$115B
LHLabcorp$361.39−1.84%+44.0%$29.34B
DGXQuest Diagnostics$251.82−0.43%+45.1%$27.70B
DVADaVita$187.50−3.01%+65.0%$11.96B
HIMSHims & Hers Health$27.68−6.71%−14.8%$6.46B